MORGAN STANLEY PLC/CALL/BECTON DICKINSON AND CO./300/0.1/21.03.25 Stock

Warrant

DE000MG0Y1N9

Real-time Bid/Ask 01:12:14 2024-05-21 pm EDT
0.25 EUR / 0.29 EUR 0.00% Intraday chart for MORGAN STANLEY PLC/CALL/BECTON DICKINSON AND CO./300/0.1/21.03.25
Current month-22.86%
1 month-28.95%
Date Price Change
24-05-21 0.26 -3.70%
24-05-20 0.27 0.00%
24-05-17 0.27 -3.57%
24-05-16 0.28 -6.67%
24-05-15 0.3 +3.45%

Delayed Quote Börse Stuttgart

Last update May 21, 2024 at 04:14 am EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN MG0Y1N
ISINDE000MG0Y1N9
Date issued 2024-03-27
Strike 300 $
Maturity 2025-03-21 (304 Days)
Parity 10 : 1
Emission price 0.43
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.65
Lowest since issue 0.26
Delta0.15x
Omega 11.32
Premium28.6x
Gearing77.54x
Moneyness 0.7855
Difference Strike 64.8 $
Difference Strike %+21.60%
Spread 0.04
Spread %13.33%
Theoretical value 0.2800
Implied Volatility 20.37 %
Total Loss Probability 89.09 %
Intrinsic value 0.000000
Present value 0.2800
Break even 303.04 €
Theta-0.01x
Vega0.05x
Rho0.02x

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
237.1 USD
Average target price
279 USD
Spread / Average Target
+17.66%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW